Australian December Private Sector Credit 0.3% m/m (expected 0.5%)

DBD surges 105% then major holder sells $9.6M shares. Profit-taking, not fundamentals?

USAR jumps 10%+ on Canaccord upgrade & $2.8B Brazil mine buy, de-risking its magnet production plan.

AbbVie's strong sales growth & dividend outlook outshine Pfizer's stretched payout & declining revenue.

PLUG surges 72% on revenue beat, RUN down 41% despite massive sales growth. Mixed returns in renewables.

LUNR jumps 6.2% on massive USSF budget hike, but is it a buy? Defense spending surge offers potential returns.

Healthcare tech stocks up 23.6% avg. HIMS soars 94.3% on strong guidance; GDRX down 4.5% on revenue miss.

S&P 500's 303% return masks high CAPE ratio (40.4). Tech giants dominate, but narratives drive valuations like Tesla's P/E of 372.